Skip to content
  • Home
  • About Us
  • Shop
    • Chinese innovative drug
    • Tablets
    • Capsules
    • Injection
    • oral solution
    • Cream/Gel/Ointment
    • ophthalmic preparations
    • Nasal preparations
    • Inhalation preparation
    • Implant
    • Chinese Medicine
  • Blog
  • Contact Us
Xpharma China
Shopping cart$0.00 0
Login
  • Home
  • About Us
  • Shop
    • Chinese innovative drug
    • Tablets
    • Capsules
    • Injection
    • oral solution
    • Cream/Gel/Ointment
    • ophthalmic preparations
    • Nasal preparations
    • Inhalation preparation
    • Implant
    • Chinese Medicine
  • Blog
  • Contact Us
Xpharma China
Trulicity (Dulaglutide Injection)
  • Drug news

How much does Trulicity (Dulaglutide Injection) Cost& price without insurance in China?

TENELIA (Teneligliptin Hydrobromide Tablets)
  • Drug news

How much does TENELIA (Teneligliptin Hydrobromide Tablets) Cost& price without insurance in China?

Chuanbeiqing (Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution)
  • Drug news

How much does Chuanbeiqing (Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution) Cost& price without insurance in China?

Lijingqing (Ursodeoxycholic Acid Oral Suspension)
  • Drug news

How much does Lijingqing (Ursodeoxycholic Acid Oral Suspension) Cost& price without insurance in China?

Jiatailai (Sacituzumab Tirumotecan for Injection)
  • Drug news

How much does Jiatailai (Sacituzumab Tirumotecan for Injection) Cost& price without insurance in China?

  • Approved News

Henlius:HLX04-O achieved success in its global Phase III trial.

  • Drug development

Qilu:QLF4113 has initiated a Phase I clinical study

  • Approved News

BMS:Mezigdomide has been formally accepted for review.

  • Approved News

Fosun:PSD502 approved for marketing in China.

Zelgen
  • Approved News

Zelgen:Gecacitinib Hydrochloride received marketing approval

Hengrui
  • Approved News

Hengrui:Dalpiciclib was approved

  • Approved News

BMS:SOTYKTU™Deucravacitinibapproved for marketing in China.

Prev
1 2 3 4 5 6 7 … 26
Next
Contact us

WeChat: +86 139 2425 9988
WhatsApp : +852 9100 6363
Email: info@xpharma.com.cn

Rm F2-48, 6/F, No. 47 Guomao Road, Hainan, China

Useful Links
  • Medicines
  • Chinese innovative drug
  • Medicines Approved News
  • Drug Development News
  • Drug News
  • Privacy Policy
Email Newsletter

Subscribe to our newsletter and get 10% off your first purchase

Copyright © {2026} -Xpharma China